Institutional investors hold a majority ownership of AGN through the 89.66% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended September 2017, these large investors purchased a net $12.7 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GIC PTE LTD. (INVESTMENT MANAGEM... Bought 17.0 Million shares of Allergan
EDGEWOOD MANAGEMENT LLC Bought 869.2 Thousand shares of Allergan
FIDELITY MANAGEMENT & RESEARCH C... Bought 595.4 Thousand shares of Allergan